Literature DB >> 27452109

Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.

Schohraya Spahis1,2, Edgard Delvin1,3, Jean-Michel Borys4, Emile Levy1,2,4.   

Abstract

SIGNIFICANCE: Nonalcoholic fatty liver disease (NAFLD), characterized by liver triacylglycerol build-up, has been growing in the global world in concert with the raised prevalence of cardiometabolic disorders, including obesity, diabetes, and hyperlipemia. Redox imbalance has been suggested to be highly relevant to NAFLD pathogenesis. Recent Advances: As a major health problem, NAFLD progresses to the more severe nonalcoholic steatohepatitis (NASH) condition and predisposes susceptible individuals to liver and cardiovascular disease. Although NAFLD represents the predominant cause of chronic liver disorders, the mechanisms of its development and progression remain incompletely understood, even if various scientific groups ascribed them to the occurrence of insulin resistance, dyslipidemia, inflammation, and apoptosis. Nevertheless, oxidative stress (OxS) more and more appears as the most important pathological event during NAFLD development and the hallmark between simple steatosis and NASH manifestation. CRITICAL ISSUES: The purpose of this article is to summarize recent developments in the understanding of NAFLD, essentially focusing on OxS as a major pathogenetic mechanism. Various attempts to translate reactive oxygen species (ROS) scavenging by antioxidants into experimental and clinical studies have yielded mostly encouraging results. FUTURE DIRECTIONS: Although augmented concentrations of ROS and faulty antioxidant defense have been associated to NAFLD and related complications, mechanisms of action and proofs of principle should be highlighted to support the causative role of OxS and to translate its concept into the clinic. Antioxid. Redox Signal. 26, 519-541.

Entities:  

Keywords:  antioxidants; cardiometabolic disorders; liver steatosis; mitochondria; reactive oxygen species; treatment

Mesh:

Substances:

Year:  2016        PMID: 27452109     DOI: 10.1089/ars.2016.6776

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  85 in total

1.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

2.  Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.

Authors:  Rohitash Jamwal; Suzanne M de la Monte; Ken Ogasawara; Sravani Adusumalli; Benjamin B Barlock; Fatemeh Akhlaghi
Journal:  Mol Pharm       Date:  2018-06-11       Impact factor: 4.939

Review 3.  Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.

Authors:  Hiroshi Kitamura
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

4.  Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.

Authors:  Francesco Baratta; Daniele Pastori; Licia Polimeni; Tommaso Bucci; Fabrizio Ceci; Cinzia Calabrese; Ilaria Ernesti; Gaetano Pannitteri; Francesco Violi; Francesco Angelico; Maria Del Ben
Journal:  Am J Gastroenterol       Date:  2017-10-24       Impact factor: 10.864

5.  Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.

Authors:  Gai Gao; Zhishen Xie; Er-Wen Li; Yong Yuan; Yu Fu; Pan Wang; Xiaowei Zhang; Yonghui Qiao; Jiangyan Xu; Christian Hölscher; Hui Wang; Zhenqiang Zhang
Journal:  J Nat Med       Date:  2021-02-15       Impact factor: 2.343

6.  Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shanshan Jin; Suwen Jiang; Airong Hu
Journal:  Sleep Breath       Date:  2018-01-15       Impact factor: 2.816

Review 7.  Molecular pathways of nonalcoholic fatty liver disease development and progression.

Authors:  Fernando Bessone; María Valeria Razori; Marcelo G Roma
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

Review 8.  Danger signals in liver injury and restoration of homeostasis.

Authors:  Hui Han; Romain Desert; Sukanta Das; Zhuolun Song; Dipti Athavale; Xiaodong Ge; Natalia Nieto
Journal:  J Hepatol       Date:  2020-05-01       Impact factor: 25.083

9.  Evaluation of Hepatoprotective Activity of the Crude Extract and Solvent Fractions of Clutia abyssinica (Euphorbiaceae) Leaf Against CCl4-Induced Hepatotoxicity in Mice.

Authors:  Birhanu Geta Meharie; Gedefaw Getnet Amare; Yaschilal Muche Belayneh
Journal:  J Exp Pharmacol       Date:  2020-06-09

10.  Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Qian Lin; Zhifeng Huang; Genxiang Cai; Xia Fan; Xiaoqing Yan; Zhengshuai Liu; Zehua Zhao; Jingya Li; Jia Li; Hongxue Shi; Maiying Kong; Ming-Hua Zheng; Daniel J Conklin; Paul N Epstein; Kupper A Wintergerst; Moosa Mohammadi; Lu Cai; Xiaokun Li; Yu Li; Yi Tan
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.